Long-term IGF-I treatment of children with Laron syndrome increases adiposity
Authors:
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 16 (1) , 61-64
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Characterization of differentiated subcutaneous and visceral adipose tissue from childrenJournal of Lipid Research, 2005
- How does rhIGF-I Replacement Improve Insulin Sensitivity in Insulin Dependent Diabetes Mellitus?Journal of Pediatric Endocrinology and Metabolism, 1997
- Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-Like Growth Factor I GeneNew England Journal of Medicine, 1996
- Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatmentMetabolism, 1995
- Insulin-Like Growth Factor I Improves Height in Growth Hormone Insensitivity: Two Years’ ResultsHormone Research, 1995
- Three Year IGF-I Treatment of Children with Laron SyndromeJournal of Pediatric Endocrinology and Metabolism, 1995
- IGF‐I treatment of adult patients with Laron syndrome: preliminary resultsClinical Endocrinology, 1994
- Body Fat in Laron Syndrome Patients: Effect of Insulin-Like Growth Factor I TreatmentHormone Research, 1993
- Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfismThe Lancet, 1992
- Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cellsExperimental Cell Research, 1987